Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt
REYKJAVIK, Iceland and MORRISTOWN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- Alvogen Pharma US, Inc. (“Alvogen” or the “Company”), a privately owned US-based pharmaceutical company ...
MORRISTOWN, N.J., March 7, 2025 /PRNewswire/ -- Alvogen Pharma US, Inc. ("Alvogen" or the "Company"), a privately owned US-based pharmaceutical company, announced the successful completion of a ...
Alvogen Pharma US Inc. has arranged a new private loan led by Centerbridge Partners that will ease near-term refinancing pressure as the generic drugs maker grapples with projected revenue ...
“This is an industry which requires a high level of investment, has relatively high barriers to entry and superior quality requirements compared to other industries,” said Robert Wessman, CEO and ...
(Submitted photo) NORWICH — The Alvogen Company is a part of a local pharmaceutical manufacturing history that goes back 130 years. The company has a pharmaceutical plant in Norwich and operates ...
Investing.com -- Moody’s Ratings has upgraded the ratings of Alvogen Pharma US, Inc., including the Corporate Family Rating (CFR) to Caa1 from Caa2, and the Probability of Default Rating to Caa1 ...
ABOUT ALVOGEN Alvogen is a privately-owned company focused on developing, in-licensing, manufacturing and marketing pharmaceutical products. Alvogen is growing its portfolio of complex, high value ...
Investing.com -- Moody’s Ratings has upgraded the ratings of Alvogen Pharma US, Inc., including the Corporate Family Rating (CFR) to Caa1 from Caa2, and the Probability of Default Rating to Caa1-PD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results